Brain-gut axis in the pathogenesis of Helicobacter pylori infection

World Journal of Gastroenterology

Volumn 20, Issue 18, 2014, Pages 5212-5225

  Budzyński, Jacek ^a   Kłopocka, Maria ^a  

^a NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

Behavior; Brain gut axis; Gastric acid; Helicobacter pylori; Motility; Visceral hypersensitivity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CORTICOTROPIN RELEASING FACTOR;

APPETITE; ARTICLE; AUTONOMIC NERVOUS SYSTEM; BRAIN; CELL INFILTRATION; CHRONIC GASTRITIS; COGNITION; CONTROLLED CLINICAL TRIAL (TOPIC); DEPRESSION; ENDOCRINE FUNCTION; FEEDING BEHAVIOR; FOOD INTAKE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL SECRETION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HOST PATHOGEN INTERACTION; HUMAN; HYPERSENSITIVITY; IMMUNE RESPONSE; INTESTINE; INTESTINE MUCOSA PERMEABILITY; MAST CELL; MENTAL DISEASE; META ANALYSIS (TOPIC); NEUROGENIC INFLAMMATION; NONHUMAN; SIGNAL TRANSDUCTION; VAGUS NERVE; WEIGHT CONTROL; ACUTE DISEASE; ANIMAL; BODY WEIGHT; CHRONIC DISEASE; GASTROINTESTINAL TRACT; IMMUNOLOGY; INNERVATION; INTESTINE INNERVATION; MICROBIOLOGY; PATHOGENICITY; PATHOPHYSIOLOGY; PSYCHOLOGY; SYNAPTIC TRANSMISSION;

ACUTE DISEASE; ANIMALS; APPETITE REGULATION; BODY WEIGHT; BRAIN; CHRONIC DISEASE; COGNITION; ENTERIC NERVOUS SYSTEM; FEEDING BEHAVIOR; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HOST-PATHOGEN INTERACTIONS; HUMANS; MAST CELLS; SYNAPTIC TRANSMISSION;

EID: 84900411608     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v20.i18.5212     Document Type: Article

References (153)

1. Melmed RN, Gelpin Y. Duodenal ulcer: the helicobacterization of a psychosomatic disease? Isr J Med Sci 1996; 32: 211-216 [PMID: 8606137]
2. Moriya M, Uehara A, Okumura T, Miyamoto M, Kohgo Y. Stress-induced hemorrhagic gastric ulcer after successful Helicobacter pylori eradication: two case reports. J Med Case Rep 2011; 5: 252 [PMID: 21714884 DOI: 10.1186/1752-1947-5-252]
3. Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ. Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut 2012; 61: 646-664 [PMID: 22491499 DOI: 10.1136/gutjnl-2012-302084]
4. Stenström B, Mendis A, Marshall B. Helicobacter pylori--the latest in diagnosis and treatment. Aust Fam Physician 2008; 37: 608-612 [PMID: 18704207]
5. Aoyama N, Shinoda Y, Matsushima Y, Shirasaka D, Kinoshita Y, Kasuga M, Chiba T. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress? J Gastroenterol 2000; 35 Suppl 12: 33-37 [PMID: 10779215]
6. Konturek PC, Brzozowski T, Konturek SJ. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol 2011; 62: 591-599 [PMID: 22314561]
7. Svoboda P, Kantorova I, Scheer P, Doubek J, Ochmann J, Rehorkova D, Bosakova H. Helicobacter pylori is not a risk factor for stress ulcer bleeding in polytraumatized patients. Hepatogastroenterology 2004; 51: 476-480 [PMID: 15086186]
8. van der Voort PH, van der Hulst RW, Zandstra DF, Geraedts AA, van der Ende A, Tytgat GN. Prevalence of Helicobacter pylori infection in stress-induced gastric mucosal injury. Intensive Care Med 2001; 27: 68-73 [PMID: 11280676]
9. Keohane J, Quigley EM. Functional dyspepsia: the role of visceral hypersensitivity in its pathogenesis. World J Gastroenterol 2006; 12: 2672-2676 [PMID: 16718751]
10. Charpignon C, Lesgourgues B, Pariente A, Nahon S, Pelaquier A, Gatineau-Sailliant G, Roucayrol AM, Courillon-Mallet A. Peptic ulcer disease: one in five is related to neither Helicobacter pylori nor aspirin/NSAID intake. Aliment Pharmacol Ther 2013; 38: 946-954 [PMID: 23981105 DOI: 10.1111/apt.12465]
11. Jones MP. The role of psychosocial factors in peptic ulcer disease: beyond Helicobacter pylori and NSAIDs. J Psychosom Res 2006; 60: 407-412 [PMID: 16581366]
12. Chen TS, Chang FY. Clinical characteristics of Helicobacter pylori-negative duodenal ulcer disease. Hepatogastroenterology 2008; 55: 1615-1618 [PMID: 19102353]
13. Goodwin RD, Talley NJ, Hotopf M, Cowles RA, Galea S, Jacobi F. A link between physician-diagnosed ulcer and anxiety disorders among adults. Ann Epidemiol 2013; 23: 189-192 [PMID: 23453387 DOI: 10.1016/j.annepidem.2013.01.003]
14. Caso JR, Leza JC, Menchén L. The effects of physical and psychological stress on the gastro-intestinal tract: lessons from animal models. Curr Mol Med 2008; 8: 299-312 [PMID: 18537637]
15. Collins SM, Denou E, Verdu EF, Bercik P. The putative role of the intestinal microbiota in the irritable bowel syndrome. Dig Liver Dis 2009; 41: 850-853 [PMID: 19740713 DOI: 10.1016/j.dld.2009.07.023]
16. Mach T. The brain-gut axis in irritable bowel syndrome--clinical aspects. Med Sci Monit 2004; 10: RA125-RA131 [PMID: 15173682]
17. Luther J, Dave M, Higgins PD, Kao JY. Association between Helicobacter pylori infection and inflammatory bowel disease: a meta-analysis and systematic review of the literature. Inflamm Bowel Dis 2010; 16: 1077-1084 [PMID: 19760778 DOI: 10.1002/ibd.21116]
18. Mayer EA, Tillisch K, Bradesi S. Review article: modulation of the brain-gut axis as a therapeutic approach in gastrointestinal disease. Aliment Pharmacol Ther 2006; 24: 919-933 [PMID: 16948804]
19. Bercik P, Verdú EF, Foster JA, Lu J, Scharringa A, Kean I, Wang L, Blennerhassett P, Collins SM. Role of gut-brain axis in persistent abnormal feeding behavior in mice following eradication of Helicobacter pylori infection. Am J Physiol Regul Integr Comp Physiol 2009; 296: R587-R594 [PMID: 19129375 DOI: 10.1152/ajpregu.90752.2008]
20. Simrén M, Vos R, Janssens J, Tack J. Unsuppressed postprandial phasic contractility in the proximal stomach in functional dyspepsia: relevance to symptoms. Am J Gastroenterol 2003; 98: 2169-2175 [PMID: 14572563]
21. Wood JD. Neuropathophysiology of functional gastrointestinal disorders. World J Gastroenterol 2007; 13: 1313-1332 [PMID: 17457962]
22. Ziemssen T, Kern S. Psychoneuroimmunology--cross-talk between the immune and nervous systems. J Neurol 2007; 254 Suppl 2: II8-I11 [PMID: 17503136 DOI: 10.1007/s00415-007-2003-8]
23. Fukuda Y, Bamba H, Okui M, Tamura K, Tanida N, Satomi M, Shimoyama T, Nishigami T. Helicobacter pylori infection increases mucosal permeability of the stomach and intestine. Digestion 2001; 63 Suppl 1: 93-96 [PMID: 11173917]
24. Neufeld KA, Kang N, Bienenstock J, Foster JA. Effects of intestinal microbiota on anxiety-like behavior. Commun Integr Biol 2011; 4: 492-494 [PMID: 21966581]
25. Neufeld KM, Kang N, Bienenstock J, Foster JA. Reduced anxiety-like behavior and central neurochemical change in germ-free mice. Neurogastroenterol Motil 2011; 23: 255-64, e119 [PMID: 21054680 DOI: 10.1111/j.1365-2982.2010.01620. x]
26. Rhee SH, Pothoulakis C, Mayer EA. Principles and clinical implications of the brain-gut-enteric microbiota axis. Nat Rev Gastroenterol Hepatol 2009; 6: 306-314 [PMID: 19404271 DOI: 10.1038/nrgastro.2009.35]
27. Cryan JF, Dinan TG. Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nat Rev Neurosci 2012; 13: 701-712 [PMID: 22968153 DOI: 10.1038/ nrn3346]
28. Neary NM, Small CJ, Bloom SR. Gut and mind. Gut 2003; 52: 918-921 [PMID: 12801943]
29. Swiatkowski M, Budzyński J, Kłopocka M, Ziółkowski M, Bujak R, Sinkiewicz W. Parameters of the functional and morphological status of the upper digestive tract in alcoholdependent male patients with depression and alexithymia in the context of autonomic nervous system activity and nitric oxide plasma level. Med Sci Monit 2004; 10: CR68-CR74 [PMID: 14737046]
30. Bajaj JS, Hylemon PB, Ridlon JM, Heuman DM, Daita K, White MB, Monteith P, Noble NA, Sikaroodi M, Gillevet PM. Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 2012; 303: G675-G685 [PMID: 22821944 DOI: 10.1152/ajpgi.00152.2012]
31. Ledochowski M, Widner B, Bair H, Probst T, Fuchs D. Fructose-and sorbitol-reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroenterol 2000; 35: 1048-1052 [PMID: 11099057]
32. Sandler RH, Finegold SM, Bolte ER, Buchanan CP, Maxwell AP, Väisänen ML, Nelson MN, Wexler HM. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J Child Neurol 2000; 15: 429-435 [PMID: 10921511]
33. Parracho HM, Bingham MO, Gibson GR, McCartney AL. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J Med Microbiol 2005; 54: 987-991 [PMID: 16157555]
34. Finegold SM, Downes J, Summanen PH. Microbiology of regressive autism. Anaerobe 2012; 18: 260-262 [PMID: 22202440 DOI: 10.1016/j.anaerobe.2011.12.018]
35. Budzyński J, Kłopocka M, Bujak R, Swiatkowski M, Pulkowski G, Sinkiewicz W. Autonomic nervous function in Helicobacter pylori-infected patients with atypical chest pain studied by analysis of heart rate variability. Eur J Gastroenterol Hepatol 2004; 16: 451-457 [PMID: 15097036]
36. Katoh K, Nomura M, Nakaya Y, Iga A, Nada T, Hiasa A, Ochi Y, Kawaguchi R, Uemura N, Honda H, Shimizu I, Ito S. Autonomic nervous activity before and after eradication of Helicobacter pylori in patients with chronic duodenal ulcer. Aliment Pharmacol Ther 2002; 16 Suppl 2: 180-186 [PMID: 11966539]
37. Gentile S, Turco S, Oliviero B, Torella R. The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 1998; 42: 41-48 [PMID: 9884032]
38. Nomura M, Yukinaka M, Miyajima H, Nada T, Kondo Y, Okahisa T, Shibata H, Okamura S, Honda H, Shimizu I, Saito K, Oki T, Nakaya Y, Ito S. Is autonomic dysfunction a necessary condition for chronic peptic ulcer formation? Aliment Pharmacol Ther 2000; 14 Suppl 1: 82-86 [PMID: 10807408]
39. Lucini D, Cerchiello M, Basilisco G, Cainelli M, Bianchi PA, Fiorelli G, Malliani A, Pagani M. Autonomic control of heart period in duodenal ulcer patients insights from spectral analysis of heart rate variability. Auton Neurosci 2000; 84: 122-129 [PMID: 11111844]
40. Sharma A, Lelic D, Brock C, Paine P, Aziz Q. New technologies to investigate the brain-gut axis. World J Gastroenterol 2009; 15: 182-191 [PMID: 19132768]
41. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006; 130: 1480-1491 [PMID: 16678561]
42. Su YC, Wang WM, Wang SY, Lu SN, Chen LT, Wu DC, Chen CY, Jan CM, Horowitz M. The association between Helicobacter pylori infection and functional dyspepsia in patients with irritable bowel syndrome. Am J Gastroenterol 2000; 95: 1900-1905 [PMID: 10950033]
43. Gerards C, Leodolter A, Glasbrenner B, Malfertheiner P. H. pylori infection and visceral hypersensitivity in patients with irritable bowel syndrome. Dig Dis 2001; 19: 170-173 [PMID: 11549828]
44. Breckan RK, Asfeldt AM, Straume B, Florholmen J, Paulssen EJ. Prevalence, comorbidity, and risk factors for functional bowel symptoms: a population-based survey in Northern Norway. Scand J Gastroenterol 2012; 47: 1274-1282 [PMID: 23061445 DOI: 10.3109/00365521.2012.688215]
45. Domínguez-Muñoz JE, Malfertheiner P. Effect of Helicobacter pylori infection on gastrointestinal motility, pancreatic secretion and hormone release in asymptomatic humans. Scand J Gastroenterol 2001; 36: 1141-1147 [PMID: 11686212]
46. Xiang Z, Chen YP, Ye YF, Ma KF, Chen SH, Zheng L, Yang YD, Jin X. Helicobacter pylori and Crohn's disease: a retrospective single-center study from China. World J Gastroenterol 2013; 19: 4576-4581 [PMID: 23901235 DOI: 10.3748/wjg. v19.i28.4576]
47. Grundy D, Al-Chaer ED, Aziz Q, Collins SM, Ke M, Taché Y, Wood JD. Fundamentals of neurogastroenterology: basic science. Gastroenterology 2006; 130: 1391-1411 [PMID: 16678554]
48. Marques AH, Silverman MN, Sternberg EM. Evaluation of stress systems by applying noninvasive methodologies: measurements of neuroimmune biomarkers in the sweat, heart rate variability and salivary cortisol. Neuroimmunomodulation 2010;17: 205-8 [PMID: 20134204 DOI: 10.1159/000258725]
49. Budzyński J, Pulkowski G, Suppan K, Fabisiak J, Majer M, Kłopocka M, Galus-Pulkowska B, Wasielewski M. Improve-ment in health-related quality of life after therapy with omeprazole in patients with coronary artery disease and recurrent angina-like chest pain. A double-blind, placebo-controlled trial of the SF-36 survey. Health Qual Life Outcomes 2011; 9: 77 [PMID: 21939510 DOI: 10.1186/1477-7525-9-77]
50. Wilhelmsen I. Quality of life and Helicobacter pylori eradication. Scand J Gastroenterol Suppl 1996; 221: 18-20 [PMID: 9110391]
51. Kountouras J, Deretzi G, Zavos C, Tsiptsios D, Gavalas E, Vardaka E, Polyzos SA, Klonizakis P, Kyriakou P. Helicobacter pylori infection may trigger Guillain-Barré syndrome, Fisher syndrome and Bickerstaff brainstem encephalitis. J Neurol Sci 2011; 305: 167-18; author reply 169 [PMID: 21440259 DOI: 10.1016/j.jns.2011.03.015]
52. Kountouras J, Zavos C, Deretzi G, Polyzos SA, Katsinelos P, Anastasiadou K, Stergiopoulos C, Pilpilidis I, Klonizakis P, Boura P, Tzilves D. Helicobacter pylori might be a potential therapeutic target in epilepsy. Med Hypotheses 2011; 76: 763 [PMID: 21356577 DOI: 10.1016/j.mehy.2011.02.004]
53. Deretzi G, Kountouras J, Grigoriadis N, Zavos C, Chatzigeorgiou S, Koutlas E, Tsiptsios I. From the "little brain" gastrointestinal infection to the "big brain" neuroinflammation: a proposed fast axonal transport pathway involved in multiple sclerosis. Med Hypotheses 2009; 73: 781-787 [PMID: 19467574 DOI: 10.1016/j.mehy.2009.04.021]
54. Eom KS, Park MR, Choi KH, Kim TY. Gastric mucosaassociated lymphoid tissue lymphoma followed by primary central nervous system lymphoma. J Korean Neurosurg Soc 2012; 51: 377-379 [PMID: 22949970]
55. Ulasoglu C, Isbilen B, Doganay L, Ozen F, Kiziltas S, Tuncer I. Effect of Helicobacter pylori eradication on serum ghrelin and obestatin levels. World J Gastroenterol 2013; 19: 2388-2394 [PMID: 23613634 DOI: 10.3748/wjg.v19.i15.2388]
56. Bercík P, De Giorgio R, Blennerhassett P, Verdú EF, Barbara G, Collins SM. Immune-mediated neural dysfunction in a murine model of chronic Helicobacter pylori infection. Gastroenterology 2002; 123: 1205-1215 [PMID: 12360482]
57. Lagunes-Servin H, Torres J, Maldonado-Bernal C, Pérez-Rodríguez M, Huerta-Yépez S, Madrazo de la Garza A, Muñoz-Pérez L, Flores-Luna L, Ramón-García G, Camorlinga-Ponce M. Toll-like receptors and cytokines are upregulated during Helicobacter pylori infection in children. Helicobacter 2013; 18: 423-432 [PMID: 23869400 DOI: 10.1111/hel.12067]
58. Rahimi HR, Rasouli M, Jamshidzadeh A, Farshad S, Firoozi MS, Taghavi AR, Kiany S. New immunological investigations on Helicobacter pylori-induced gastric ulcer in patients. Microbiol Immunol 2013; 57: 455-462 [PMID: 23773024]
59. Romero-Adrián TB, Leal-Montiel J, Monsalve-Castillo F, Mengual-Moreno E, McGregor EG, Perini L, Antúnez A. Helicobacter pylori: bacterial factors and the role of cytokines in the immune response. Curr Microbiol 2010; 60: 143-155 [PMID: 19847485]
60. Vizi ES, Elenkov IJ. Nonsynaptic noradrenaline release in neuro-immune responses. Acta Biol Hung 2002; 53: 229-244 [PMID: 12064774]
61. Peuhkuri K, Vapaatalo H, Korpela R. Even low-grade inflammation impacts on small intestinal function. World J Gastroenterol 2010; 16: 1057-1062 [PMID: 20205274]
62. Molnar B, Galamb O, Sipos F, Leiszter K, Tulassay Z. Molecular pathogenesis of Helicobacter pylori infection: the role of bacterial virulence factors. Dig Dis 2010; 28: 604-608 [PMID: 21088410 DOI: 10.1159/000320060]
63. Guo G, Jia KR, Shi Y, Liu XF, Liu KY, Qi W, Guo Y, Zhang WJ, Wang T, Xiao B, Zou QM. Psychological stress enhances the colonization of the stomach by Helicobacter pylori in the BALB/c mouse. Stress 2009; 12: 478-485 [PMID: 20102319 DOI: 10.3109/10253890802642188]
64. Ding H, Nedrud JG, Wershil B, Redline RW, Blanchard TG, Czinn SJ. Partial protection against Helicobacter pylori in the absence of mast cells in mice. Infect Immun 2009; 77: 5543-5550 [PMID: 19822650 DOI: 10.1128/IAI.00532-09]
65. Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, Cakal E, Serter R, Aral Y. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005; 28: 214-217 [PMID: 15952404]
66. Tack J, Caenepeel P, Fischler B, Piessevaux H, Janssens J. Symptoms associated with hypersensitivity to gastric distention in functional dyspepsia. Gastroenterology 2001; 121: 526-535 [PMID: 11522735]
67. Tougas G, Spaziani R, Hollerbach S, Djuric V, Pang C, Upton AR, Fallen EL, Kamath MV. Cardiac autonomic function and oesophageal acid sensitivity in patients with noncardiac chest pain. Gut 2001; 49: 706-712 [PMID: 11600476]
68. Testoni PA, Bagnolo F, Bologna P, Colombo E, Bonassi U, Lella F, Buizza M. Higher prevalence of Helicobacter pylori infection in dyspeptic patients who do not have gastric phase III of the migrating motor complex. Scand J Gastroenterol 1996; 31: 1063-1068 [PMID: 8938898]
69. Chang CS, Chen GH, Kao CH, Wang SJ. Delayed gastric emptying does not predispose to Helicobacter pylori infection in non-ulcer dyspepsia patients. Nucl Med Commun 1995; 16: 1063-1067 [PMID: 8719989]
70. Hall W, Buckley M, Crotty P, O'Morain CA. Gastric mucosal mast cells are increased in Helicobacter pylori-negative functional dyspepsia. Clin Gastroenterol Hepatol 2003; 1: 363-369 [PMID: 15017654]
71. Sipos G, Altdorfer K, Pongor E, Chen LP, Fehér E. Neuroimmune link in the mucosa of chronic gastritis with Helicobacter pylori infection. Dig Dis Sci 2006; 51: 1810-1817 [PMID: 16983504]
72. Supajatura V, Ushio H, Wada A, Yahiro K, Okumura K, Ogawa H, Hirayama T, Ra C. Cutting edge: VacA, a vacuolating cytotoxin of Helicobacter pylori, directly activates mast cells for migration and production of proinflammatory cytokines. J Immunol 2002; 168: 2603-2607 [PMID: 11884423]
73. Nakajima S, Bamba N, Hattori T. Histological aspects and role of mast cells in Helicobacter pylori-infected gastritis. Aliment Pharmacol Ther 2004; 20 Suppl 1: 165-170 [PMID: 15298623]
74. Otaka M, Watanabe S. Role of mucosal mast cells in Helicobacter pylori infection. J Gastroenterol 2002; 37: 70-72 [PMID: 11824805]
75. Montemurro P, Nishioka H, Dundon WG, de Bernard M, Del Giudice G, Rappuoli R, Montecucco C. The neutrophilactivating protein (HP-NAP) of Helicobacter pylori is a potent stimulant of mast cells. Eur J Immunol 2002; 32: 671-676 [PMID: 11857341]
76. Miwa H. Why dyspepsia can occur without organic disease: pathogenesis and management of functional dyspepsia. J Gastroenterol 2012; 47: 862-871 [PMID: 22766746 DOI: 10.1007/s00535-012-0625-9]
77. Gaykema RP, Goehler LE, Lyte M. Brain response to cecal infection with Campylobacter jejuni: analysis with Fos immunohistochemistry. Brain Behav Immun 2004; 18: 238-245 [PMID: 15050651]
78. Rossetto O, de Bernard M, Pellizzari R, Vitale G, Caccin P, Schiavo G, Montecucco C. Bacterial toxins with intracellular protease activity. Clin Chim Acta 2000; 291: 189-199 [PMID: 10675723]
79. Kountouras J, Zavos C, Deretzi G, Gavalas E, Chatzopoulos D, Katsinelos P, Tsiaousi E, Gagalis S, Polyzos SA, Venizelos I. Potential implications of Helicobacter pylori-related neutrophil-activating protein. World J Gastroenterol 2012; 18: 489-490 [PMID: 22346256 DOI: 10.3748/wjg.v18.i5.489]
80. Deretzi G, Kountouras J, Polyzos SA, Zavos C, Giartza-Taxidou E, Gavalas E, Tsiptsios I. Gastrointestinal immune system and brain dialogue implicated in neuroinflammatory and neurodegenerative diseases. Curr Mol Med 2011; 11: 696-707 [PMID: 21902649]
81. Suzuki H, Matsuzaki J, Hibi T. Ghrelin and oxidative stress in gastrointestinal tract. J Clin Biochem Nutr 2011; 48: 122-125 [PMID: 21373264 DOI: 10.3164/jcbn.10-16GFR]
82. Suzuki H, Miura S, Suzuki M, Terada S, Nakamura M, Tsuchiya M. Gastric mucosal injury: microcirculation and Helicobacter pylori. Keio J Med 1994; 43: 1-8 [PMID: 8189675]
83. Li XB, Chen HM, Lu H, Zheng Q, Chen XY, Peng YS, Ge ZZ, Liu WZ. Role of Helicobacter pylori infection on neuronal expression in the stomach and spinal cord of a murine model. J Dig Dis 2009; 10: 286-292 [PMID: 19906107 DOI: 10.1111/j.1751-2980.2009.00397.x]
84. Xu X, Li Z, Zou D, Yang M, Liu Z, Wang X. High expression of calcitonin gene-related peptide and substance P in esophageal mucosa of patients with non-erosive reflux disease. Dig Dis Sci 2013; 58: 53-60 [PMID: 22961239 DOI: 10.1007/s10620-012-2308-z]
85. Erin N, Türker S, Elpek O, Yi{dotless}ldi{dotless}ri{dotless}m B. Differential changes in Substance P, VIP as well as neprilysin levels in patients with gastritis or ulcer. Peptides 2012; 35: 218-224 [PMID: 22484287 DOI: 10.1016/j.peptides.2012.03.018]
86. Yaǧci M, Yamaç K, Acar K, Cingi E, Kitapçi M, Haznedar R. Gastric emptying in patients with vitamin B(12) deficiency. Eur J Nucl Med Mol Imaging 2002; 29: 1125-1127 [PMID: 12192555]
87. Aebischer T, Fischer A, Walduck A, Schlötelburg C, Lindig M, Schreiber S, Meyer TF, Bereswill S, Göbel UB. Vaccination prevents Helicobacter pylori-induced alterations of the gastric flora in mice. FEMS Immunol Med Microbiol 2006; 46: 221-229 [PMID: 16487303]
88. Myllyluoma E, Ahlroos T, Veijola L, Rautelin H, Tynkkynen S, Korpela R. Effects of anti-Helicobacter pylori treatment and probiotic supplementation on intestinal microbiota. Int J Antimicrob Agents 2007; 29: 66-72 [PMID: 17141481]
89. Engstrand L, Lindberg M. Helicobacter pylori and the gastric microbiota. Best Pract Res Clin Gastroenterol 2013; 27: 39-45 [PMID: 23768551 DOI: 10.1016/j.bpg.2013.03.016]
90. Dömötör A, Kereskay L, Szekeres G, Hunyady B, Szolcsányi J, Mózsik G. Participation of capsaicin-sensitive afferent nerves in the gastric mucosa of patients with Helicobacter pylori-positive or-negative chronic gastritis. Dig Dis Sci 2007; 52: 411-417 [PMID: 17195120]
91. D'Elios MM, Appelmelk BJ, Amedei A, Bergman MP, Del Prete G. Gastric autoimmunity: the role of Helicobacter pylori and molecular mimicry. Trends Mol Med 2004; 10: 316-323 [PMID: 15242679]
92. Amedei A, Munari F, Bella CD, Niccolai E, Benagiano M, Bencini L, Cianchi F, Farsi M, Emmi G, Zanotti G, de Bernard M, Kundu M, D'Elios MM. Helicobacter pylori secreted peptidyl prolyl cis, trans-isomerase drives Th17 inflammation in gastric adenocarcinoma. Intern Emerg Med 2014; 9: 303-309 [PMID: 23054412]
93. Gareau MG, Wine E, Rodrigues DM, Cho JH, Whary MT, Philpott DJ, Macqueen G, Sherman PM. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011; 60: 307-317 [PMID: 20966022 DOI: 10.1136/ gut.2009.202515]
94. Suzuki H, Moayyedi P. Helicobacter pylori infection in functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10: 168-174 [PMID: 23358394 DOI: 10.1038/nrgastro.2013.9]
95. Chauhan A, Mullins PA, Taylor G, Petch MC, Schofield PM. Cardioesophageal reflex: a mechanism for "linked angina" in patients with angiographically proven coronary artery disease. J Am Coll Cardiol 1996; 27: 1621-1628 [PMID: 8636546]
96. Akkaya N, Akkaya S, Polat Y, Turk M, Turk T, Turhal E, Sahin F. Helicobacter pylori seropositivity in fibromyalgia syndrome. Clin Rheumatol 2011; 30: 43-49 [PMID: 21120564]
97. Lee YY, Chua AS. Influence of gut microbes on the braingut axis (Gut 2011; 60: 307-317). J Neurogastroenterol Motil 2011; 17: 427-429 [PMID: 22148116 DOI: 10.5056/ jnm.2011.17.4.427]
98. Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10: 735-742 [PMID: 23000955 DOI: 10.1038/nrmicro2876]
99. Foster JA, McVey Neufeld KA. Gut-brain axis: how the microbiome influences anxiety and depression. Trends Neurosci 2013; 36: 305-312 [PMID: 23384445 DOI: 10.1016/ j.tins.2013.01.005]
100. Yang YJ, Sheu BS. Probiotics-containing yogurts suppress Helicobacter pylori load and modify immune response and intestinal microbiota in the Helicobacter pylori-infected children. Helicobacter 2012; 17: 297-304 [PMID: 22759330 DOI: 10.1111/j.1523-5378.2012.00941.x]
101. Yang YJ, Sheu BS, Yang HB, Lu CC, Chuang CC. Eradication of Helicobacter pylori increases childhood growth and serum acylated ghrelin levels. World J Gastroenterol 2012; 18: 2674-2681 [PMID: 22690077 DOI: 10.3748/wjg.v18.i21.2674]
102. Francois F, Roper J, Joseph N, Pei Z, Chhada A, Shak JR, de Perez AZ, Perez-Perez GI, Blaser MJ. The effect of H. pylori eradication on meal-associated changes in plasma ghrelin and leptin. BMC Gastroenterol 2011; 11: 37 [PMID: 21489301 DOI: 10.1186/1471-230X-11-37]
103. Deng ZH, Chu B, Xu YZ, Zhang B, Jiang LR. Influence of Helicobacter pylori infection on ghrelin levels in children. World J Gastroenterol 2012; 18: 5096-5100 [PMID: 23049220 DOI: 10.3748/wjg.v18.i36.5096]
104. Tatsuguchi A, Miyake K, Gudis K, Futagami S, Tsukui T, Wada K, Kishida T, Fukuda Y, Sugisaki Y, Sakamoto C. Effect of Helicobacter pylori infection on ghrelin expression in human gastric mucosa. Am J Gastroenterol 2004; 99: 2121-2127 [PMID: 15554990]
105. Weigt J, Malfertheiner P. Influence of Helicobacter pylori on gastric regulation of food intake. Curr Opin Clin Nutr Metab Care 2009; 12: 522-525 [PMID: 19584718 DOI: 10.1097/ MCO.0b013e32832eb56e]
106. Roper J, Francois F, Shue PL, Mourad MS, Pei Z, Olivares de Perez AZ, Perez-Perez GI, Tseng CH, Blaser MJ. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab 2008; 93: 2350-2357 [PMID: 18397989 DOI: 10.1210/jc.2007-2057]
107. Jang EJ, Park SW, Park JS, Park SJ, Hahm KB, Paik SY, Sin MK, Lee ES, Oh SW, Park CY, Baik HW. The influence of the eradication of Helicobacter pylori on gastric ghrelin, appetite, and body mass index in patients with peptic ulcer disease. J Gastroenterol Hepatol 2008; 23 Suppl 2: S278-S285 [PMID: 19120912 DOI: 10.1111/j.1440-1746.2008.05415.x]
108. Osawa H, Kita H, Ohnishi H, Nakazato M, Date Y, Bowlus CL, Ishino Y, Watanabe E, Shiiya T, Ueno H, Hoshino H, Satoh K, Sugano K. Changes in plasma ghrelin levels, gastric ghrelin production, and body weight after Helicobacter pylori cure. J Gastroenterol 2006; 41: 954-961 [PMID: 17096064]
109. Choe YH, Lee JH, Lee HJ, Paik KH, Jin DK, Song SY, Lee JH. Ghrelin Levels in Gastric Mucosa before and after Eradication of Helicobacter pylori. Gut Liver 2007; 1: 132-137 [PMID: 20485629 DOI: 10.5009/gnl.2007.1.2.132]
110. Abdullahi M, Annibale B, Capoccia D, Tari R, Lahner E, Osborn J, Leonetti F, Severi C. The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg 2008; 18: 1450-1454 [PMID: 18443890 DOI: 10.1007/s11695-008-9477-z]
111. Ünal HÜ, Akin E, Aydin İ, Korkmaz M, Özel S, Selçuk H, Yilmaz U. Ongoing symptoms after eradication of Helicobacter pylori: psychiatric disorders may accompany. Turk J Gastroenterol 2013; 24: 15-21 [PMID: 23794339]
112. Kotan Z, Sarandöl E, Ki{dotless}rhan E, Ozkaya G, Ki{dotless}rli{dotless} S. Serum brain-derived neurotrophic factor, vascular endothelial growth factor and leptin levels in patients with a diagnosis of severe major depressive disorder with melancholic features. Ther Adv Psychopharmacol 2012; 2: 65-74 [PMID: 23983958 DOI: 10.1177/2045125312436572]
113. Winston JH, Sarna SK. Developmental origins of functional dyspepsia-like gastric hypersensitivity in rats. Gastroenterology 2013; 144: 570-579. e3 [PMID: 23142231 DOI: 10.1053/ j.gastro.2012.11.001]
114. Bhide AA, Cartwright R, Khullar V, Digesu GA. Biomarkers in overactive bladder. Int Urogynecol J 2013; 24: 1065-1072 [PMID: 23314226 DOI: 10.1007/s00192-012-2027-1]
115. Beydoun MA, Beydoun HA, Shroff MR, Kitner-Triolo MH, Zonderman AB. Helicobacter pylori seropositivity and cognitive performance among US adults: evidence from a large national survey. Psychosom Med 2013; 75: 486-496 [PMID: 23697465 DOI: 10.1097/PSY.0b013e31829108c3]
116. Agrawal A, Gupta A, Chandra M, Koowar S. Role of Helicobacter pylori infection in the pathogenesis of minimal hepatic encephalopathy and effect of its eradication. Indian J Gastroenterol 2011; 30: 29-32 [PMID: 21416318 DOI: 10.1007/ s12664-011-0087-7]
117. Roubaud Baudron C, Letenneur L, Langlais A, Buissonnière A, Mégraud F, Dartigues JF, Salles N. Does Helicobacter pylori infection increase incidence of dementia? The Personnes Agées QUID Study. J Am Geriatr Soc 2013; 61: 74-78 [PMID: 23252507 DOI: 10.1111/jgs.12065]
118. Muhsen K, Ornoy A, Akawi A, Alpert G, Cohen D. An association between Helicobacter pylori infection and cognitive function in children at early school age: a communitybased study. BMC Pediatr 2011; 11: 43 [PMID: 21612616 DOI: 10.1186/1471-2431-11-43]
119. Ozdemir V, Jamal MM, Osapay K, Jadus MR, Sandor Z, Hashemzadeh M, Szabo S. Cosegregation of gastrointestinal ulcers and schizophrenia in a large national inpatient discharge database: revisiting the "brain-gut axis" hypothesis in ulcer pathogenesis. J Investig Med 2007; 55: 315-320 [PMID: 17963681]
120. Dylag K, Hubalewska-Mazgaj M, Surmiak M, Szmyd J, Brzozowski T. Probiotics in the mechanism of protection against gut inflammation and therapy of gastrointestinal disorders. Curr Pharm Des 2014; 20: 1149-1155 [PMID: 23755726]
121. Nada T, Nomura M, Iga A, Kawaguchi R, Ochi Y, Saito K, Nakaya Y, Ito S. Autonomic nervous function in patients with peptic ulcer studied by spectral analysis of heart rate variability. J Med 2001; 32: 333-347 [PMID: 11958279]
122. Lugon JR, Moreira MD, de Almeida JM, Silva AS, Esberard EC, Bousquet-Santos K, Carvalho AG, Mendes LC, da Nobrega AC. Cardiovascular autonomic response to food ingestion in patients with gastritis: a comparison between Helicobacter pylori-positive and-negative patients. Helicobacter 2006; 11: 173-180 [PMID: 16684265]
123. Stanghellini V, Barbara G, de Giorgio R, Tosetti C, Cogliandro R, Cogliandro L, Salvioli B, Corinaldesi R. Review article: Helicobacter pylori, mucosal inflammation and symptom perception--new insights into an old hypothesis. Aliment Pharmacol Ther 2001; 15 Suppl 1: 28-32 [PMID: 11488659]
124. Thor PJ, Błaut U. Helicobacter pylori infection in pathogenesis of gastroesophageal reflux disease. J Physiol Pharmacol 2006; 57 Suppl 3: 81-90 [PMID: 17033107]
125. Shahabi S, Rasmi Y, Jazani NH, Hassan ZM. Protective effects of Helicobacter pylori against gastroesophageal reflux disease may be due to a neuroimmunological anti-inflammatory mechanism. Immunol Cell Biol 2008; 86: 175-178 [PMID: 17923849]
126. Mönnikes H, van der Voort IR, Wollenberg B, Heymann-Monnikes I, Tebbe JJ, Alt W, Arnold R, Klapp BF, Wiedenmann B, McGregor GP. Gastric perception thresholds are low and sensory neuropeptide levels high in helicobacter pylori-positive functional dyspepsia. Digestion 2005; 71: 111-123 [PMID: 15785037]
127. Moayyedi P, Soo S, Deeks JJ, Delaney B, Harris A, Innes M, Oakes R, Wilson S, Roalfe A, Bennett C, Forman D. WITHDRAWN: Eradication of Helicobacter pylori for non-ulcer dyspepsia. Cochrane Database Syst Rev 2011; (2): CD002096 [PMID: 21328254 DOI: 10.1002/14651858.CD002096.pub5]
128. Mearin F, de Ribot X, Balboa A, Salas A, Varas MJ, Cucala M, Bartolomé R, Armengol JR, Malagelada JR. Does Helicobacter pylori infection increase gastric sensitivity in functional dyspepsia? Gut 1995; 37: 47-51 [PMID: 7672680]
129. Danesh J, Lawrence M, Murphy M, Roberts S, Collins R. Systematic review of the epidemiological evidence on Helicobacter pylori infection and nonulcer or uninvestigated dyspepsia. Arch Intern Med 2000; 160: 1192-1198 [PMID: 10789614]
130. McColl K, Murray L, El-Omar E, Dickson A, El-Nujumi A, Wirz A, Kelman A, Penny C, Knill-Jones R, Hilditch T. Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia. N Engl J Med 1998; 339: 1869-1874 [PMID: 9862941]
131. Laine L, Schoenfeld P, Fennerty MB. Therapy for Helicobacter pylori in patients with nonulcer dyspepsia. A metaanalysis of randomized, controlled trials. Ann Intern Med 2001; 134: 361-369 [PMID: 11242496]
132. Pirtniecks A, Smith LF, Thorpe JA. Autonomic dysfunction in non-specific disorders of oesophageal motility. Eur J Cardiothorac Surg 2000; 17: 101-105 [PMID: 10731643]
133. Futagami S, Shimpuku M, Yin Y, Shindo T, Kodaka Y, Nagoya H, Nakazawa S, Fujimoto M, Izumi N, Ohishi N, Kawagoe T, Horie A, Iwakiri K, Sakamoto C. Pathophysiology of functional dyspepsia. J Nippon Med Sch 2011; 78: 280-285 [PMID: 22041874]
134. Tillisch K, Mayer EA, Labus JS, Stains J, Chang L, Naliboff BD. Sex specific alterations in autonomic function among patients with irritable bowel syndrome. Gut 2005; 54: 1396-1401 [PMID: 15923667]
135. Miyaji H, Azuma T, Ito S, Abe Y, Ono H, Suto H, Ito Y, Yamazaki Y, Kohli Y, Kuriyama M. The effect of helicobacter pylori eradication therapy on gastric antral myoelectrical activity and gastric emptying in patients with nonulcer dyspepsia. Aliment Pharmacol Ther 1999; 13: 1473-1480 [PMID: 10571604]
136. Ghoshal UC, Chourasia D. Gastroesophageal Reflux Disease and Helicobacter pylori: What May Be the Relationship? J Neurogastroenterol Motil 2010; 16: 243-250 [PMID: 20680162 DOI: 10.5056/jnm.2010.16.3.243]
137. Schenk BE, Kuipers EJ, Klinkenberg-Knol EC, Bloemena E, Nelis GF, Festen HP, Jansen EH, Biemond I, Lamers CB, Meuwissen SG. Hypergastrinaemia during long-term omeprazole therapy: influences of vagal nerve function, gastric emptying and Helicobacter pylori infection. Aliment Pharmacol Ther 1998; 12: 605-612 [PMID: 9701523]
138. Zub-Pokrowiecka A, Rembiasz K, Konturek SJ, Budzynski A, Konturek PC, Budzynski P. Ghrelin in diseases of the gastric mucosa associated with Helicobacter pylori infection. Med Sci Monit 2010; 16: CR493-CR500 [PMID: 20885354]
139. Konturek JW, Stoll R, Menzel J, Konturek M, Konturek SJ, Domschke W. Eradication of Helicobacter pylori restores the inhibitory effect of cholecystokinin on gastric motility in duodenal ulcer patients. Scand J Gastroenterol 2001; 36: 241-246 [PMID: 11305509]
140. Chiloiro M, Russo F, Riezzo G, Leoci C, Clemente C, Messa C, Di Leo A. Effect of Helicobacter pylori infection on gastric emptying and gastrointestinal hormones in dyspeptic and healthy subjects. Dig Dis Sci 2001; 46: 46-53 [PMID: 11270793]
141. Tsai SH, Chen CM, Chang CS, Chen GH. Effect of Helicobacter pylori infection on intragastric acidity in patients with reflux esophagitis. J Gastroenterol 2004; 39: 821-826 [PMID: 15565399]
142. Zerbib F, Bicheler V, Leray V, Joubert M, Bruley des Varannes S, Galmiche JP. H. pylori and transient lower esophageal sphincter relaxations induced by gastric distension in healthy humans. Am J Physiol Gastrointest Liver Physiol 2001; 281: G350-G356 [PMID: 11447014]
143. Tanaka I, Tatsumi Y, Kodama T, Kato K, Fujita S, Mitsufuji S, Kashima K. Effect of Helicobacter pylori eradication on gastroesophageal function. J Gastroenterol Hepatol 2004; 19: 251-257 [PMID: 14748870]
144. Sarnelli G, Cuomo R, Janssens J, Tack J. Symptom patterns and pathophysiological mechanisms in dyspeptic patients with and without Helicobacter pylori. Dig Dis Sci 2003; 48: 2229-2236 [PMID: 14714606]
145. Thumshirn M, Camilleri M, Saslow SB, Williams DE, Burton DD, Hanson RB. Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999; 44: 55-64 [PMID: 9862826]
146. Koskenpato J, Korppi-Tommola T, Kairemo K, Färkkilä M. Long-term follow-up study of gastric emptying and Helicobacter pylori eradication among patients with functional dyspepsia. Dig Dis Sci 2000; 45: 1763-1768 [PMID: 11052317]
147. Lin Z, Chen JD, Parolisi S, Shifflett J, Peura DA, McCallum RW. Prevalence of gastric myoelectrical abnormalities in patients with nonulcer dyspepsia and H. pylori infection: resolution after H. pylori eradication. Dig Dis Sci 2001; 46: 739-745 [PMID: 11330406]
148. Thor P, Lorens K, Tabor S, Herman R, Konturek JW, Konturek SJ. Dysfunction in gastric myoelectric and motor activity in Helicobacter pylori positive gastritis patients with nonulcer dyspesia. J Physiol Pharmacol 1996; 47: 469-476 [PMID: 8877902]
149. Manes G, Esposito P, Lioniello M, Bove A, Mosca S, Balzano A. Manometric and pH-metric features in gastro-oesophageal reflux disease patients with and without Helicobacter pylori infection. Dig Liver Dis 2000; 32: 372-377 [PMID: 11030180]
150. Giral A, Celikel CA, Ozdogan O, Tözün N, Ulusoy NB, Kalayci C. Impact of Helicobacter pylori eradication on the anti-secretory efficacy of lansoprazole in gastroesophageal reflux disease patients. J Gastroenterol Hepatol 2005; 20: 1886-1891 [PMID: 16336449]
151. Ando T, El-Omar EM, Goto Y, Nobata K, Watanabe O, Maeda O, Ishiguro K, Minami M, Hamajima N, Goto H. Interleukin 1B proinflammatory genotypes protect against gastro-oesophageal reflux disease through induction of corpus atrophy. Gut 2006; 55: 158-164 [PMID: 16120761]
152. Iijima K, Ohara S, Sekine H, Koike T, Kato K, Asaki S, Shimosegawa T, Toyota T. Changes in gastric acid secretion assayed by endoscopic gastrin test before and after Helicobacter pylori eradication. Gut 2000; 46: 20-26 [PMID: 10601049]
153. Konturek SJ, Brzozowski T, Konturek PC, Schubert ML, Pawlik WW, Padol S, Bayner J. Brain-gut and appetite regulating hormones in the control of gastric secretion and mucosal protection. J Physiol Pharmacol 2008; 59 Suppl 2: 7-31 [PMID: 18812626]